- Extra-time goal gives Germany World Cup title over Argentina
- Strong quake hits Japan, triggering tsunami
- Sniper heaven: Pentagon’s self-guided bullets leave enemies nowhere to hide
- Violent gang taking advantage of immigration crisis, using border as recruiting hub
- Medicaid enrollment continues to soar under Obamacare, administration says
- Michelle Obama to Latinos: ‘We cannot afford to wait on Congress’ for immigration
- White House urges GOP to act ‘urgently’ on $3.7 billion request for illegal immigrants
- Politicians, criminals using ‘right-to-be-forgotten’ law EU courts forced upon Google
- Combat fatigue: elite special forces troops are ‘fraying,’ Gen. Joseph Votel warns
- German foreign minister to meet Kerry to discuss spying claims
Merck to appeal $4.6M verdict in Mass. fraud case
Question of the Day
TRENTON, N.J. (AP) - Drugmaker Merck & Co. plans to appeal a federal court verdict that a former subsidiary caused the commonwealth of Massachusetts to overpay pharmacists for a widely used asthma medication, the company said Thursday.
After a three-week trial, a jury in Boston found Merck liable for about $4.6 million in compensatory damages. The judge hearing the case, U.S. District Judge Patti Saris, is to decide later on potential penalties, which Merck said could be substantial.
The three generic albuterol products involved in the case, which began in 2003, were manufactured and sold by Warrick Pharmaceuticals, a subsidiary of Schering-Plough Corp.Merck, based in Whitehouse Station, bought Schering-Plough in November 2009. Warrick closed the year before.
“The company intends to vigorously pursue a reversal of the verdict in the trial court and on appeal, if necessary,” Bruce N. Kuhlik, Merck’s general counsel, said in a statement.
Kuhlik said evidence presented at the trial showed Warrick was not responsible for the state’s choices about how much it paid Massachusetts pharmacists for the drug. Merck said evidence showed Massachusetts never required Warrick to provide information on the price at which it was selling albuterol and that the prices Warrick reported to other government entities were accurate.
Drug companies are generally required to give government health programs such as Medicaid the same prices or discounts on medication that they give to other large customers.
Albuterol is a medicine that opens up airways for patients with asthma, bronchitis and chronic obstructive pulmonary disease. Usually, albuterol is supplied through inhalers or nebulizers, devices that blow medicine particles down the throat and into the lungs.
TWT Video Picks
By Robert N. Tracci
Congress must use its appropriations power to secure the border
- DOJ investigates Nebraska parade float critical of Obama
- Agency scrubs Malia Obama photos at White House's request: report
- A 'new Cold War': China's top paper warns of 'slippery slope' towards conflict with U.S.
- Violent gang MS-13 taking advantage of immigration crisis, using border as recruiting hub
- Emeryville, Calif., police chief: Guns aren't for defense
- Pentagon's self-guided bullets leave enemies nowhere to hide
- New York City creates ID card so 500K illegal immigrants can get services
- Armed militia sets up Texas command center to 'fight for national sovereignty'
- CURL: The hypocrisy of Obama's 15-day Vineyard vacation
- Islamic State leader Abu Bakr al-Baghdadi formerly a U.S. captive
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq
World Cup's sexiest WAGs